Neurogen Corporation Announces Its First Quarter 2002 Financial Results Conference Call on the Web
BRANFORD, Conn., May 9 /PRNewswire-FirstCall/ -- In conjunction with Neurogen Corporation's First Quarter 2002 Financial Results, you are invited to listen to its conference call that will be broadcast live over the Internet on Thursday, May 9, 2002 at 10:00 a.m. Eastern.
What: Neurogen Corporation First Quarter 2002 Financial Results
When: May 9, 2002 at 10:00 a.m. Eastern
Where: videonewswire.com
How: Live over the Internet -- Simply log on to the web at
the address above.
Contact: Elaine Beckwith, 203-315-4615, elaine_beckwith@nrgn.com
Neurogen Corporation (Nasdaq: NRGN - news) is a leading small molecule drug discovery and development company targeting new drug candidates to improve the lives of patients suffering from neurological, inflammatory, and metabolic disorders. Neurogen has generated a portfolio of compelling new drug programs through its fully integrated drug discovery platform, successfully solving complex issues in the discovery of small molecule drugs for valuable targets. Neurogen's strategy is to advance a mix of proprietary drugs independently and, when advantageous, collaborate with world-class pharmaceutical companies during the drug development process to obtain additional resources and to access complementary expertise. Neurogen's Accelerated Intelligent Drug Discovery (AIDD) process and its expertise in cellular functional assays are key discriminators in the Company's ability to rapidly and cost effectively identify active compounds during the drug discovery process. |
